These Numbers Could Change Investor Views For Robinhood Markets Inc (NASDAQ: HOOD)

Currently, there are 761.99M common shares owned by the public and among those 600.17M shares have been available to trade.

The company’s stock has a 5-day price change of 20.13% and 78.80% over the past three months. HOOD shares are trading 29.23% year to date (YTD), with the 12-month market performance up to 352.11% higher. It has a 12-month low price of $10.38 and touched a high of $46.85 over the same period. HOOD has an average intraday trading volume of 22.30 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 18.82%, 27.32%, and 89.70% respectively.

Institutional ownership of Robinhood Markets Inc (NASDAQ: HOOD) shares accounts for 50.36% of the company’s 761.99M shares outstanding.

It has a market capitalization of $42.56B and a beta (3y monthly) value of 2.08. The stock’s trailing 12-month PE ratio is 82.06, while the earnings-per-share (ttm) stands at $0.59. The company has a PEG of 11.72 and the debt-to-equity ratio at 1.33. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.79% over the week and 5.90% over the month.

Earnings per share for the fiscal year are expected to increase by 252.35%, and 27.01% over the next financial year. EPS should grow at an annualized rate of 7.00% over the next five years, compared to -48.35% over the past 5-year period.

Looking at the support for the HOOD, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on January 17, 2025, with the firm’s price target at $55-$64. JP Morgan coverage for the Robinhood Markets Inc (HOOD) stock in a research note released on January 07, 2025 offered a Neutral rating with a price target of $43. Barclays was of a view on December 09, 2024 that the stock is Overweight, while Goldman gave the stock Buy rating on December 06, 2024, issuing a price target of $40- $46. Morgan Stanley on their part issued Overweight rating on November 25, 2024.

Most Popular

Related Posts